Format
Sort by

Send to

Choose Destination

Search results

Items: 5

1.

The C-terminal extension landscape of naturally presented HLA-I ligands.

Guillaume P, Picaud S, Baumgaertner P, Montandon N, Schmidt J, Speiser DE, Coukos G, Bassani-Sternberg M, Filippakopoulos P, Gfeller D.

Proc Natl Acad Sci U S A. 2018 May 15;115(20):5083-5088. doi: 10.1073/pnas.1717277115. Epub 2018 Apr 30.

2.

Long-lasting stem cell-like memory CD8+ T cells with a naïve-like profile upon yellow fever vaccination.

Fuertes Marraco SA, Soneson C, Cagnon L, Gannon PO, Allard M, Abed Maillard S, Montandon N, Rufer N, Waldvogel S, Delorenzi M, Speiser DE.

Sci Transl Med. 2015 Apr 8;7(282):282ra48. doi: 10.1126/scitranslmed.aaa3700.

3.

Frequencies of circulating MDSC correlate with clinical outcome of melanoma patients treated with ipilimumab.

Meyer C, Cagnon L, Costa-Nunes CM, Baumgaertner P, Montandon N, Leyvraz L, Michielin O, Romano E, Speiser DE.

Cancer Immunol Immunother. 2014 Mar;63(3):247-57. doi: 10.1007/s00262-013-1508-5. Epub 2013 Dec 20.

PMID:
24357148
4.

[Super intensive treatment followed by bone marrow autograft in cases of hematologic neoplasms and solid tumors].

Chapuis B, Helg C, Maurice P, Aapro M, Jeannet M, Irlé C, Montandon N, Kaestli M, Wyss M, Wacker P, et al.

Schweiz Med Wochenschr. 1988 Mar 12;118(10):341-6. Review. French.

PMID:
2452479
5.

Detection of anti-non-MHC-directed T cell reactivity following in vivo priming after HLA-identical marrow transplantation and following in vitro priming in limiting dilution cultures.

Irlé C, Chapuis B, Jeannet M, Kaestli M, Montandon N, Speck B.

Transplant Proc. 1987 Feb;19(1 Pt 3):2674-7. No abstract available.

PMID:
3547946

Supplemental Content

Loading ...
Support Center